936221-73-7 Usage
General Description
Tert-Butyl (1-cyclopentylpiperidin-4-yl)carbamate is a chemical compound that belongs to the class of carbamates. It is often used as a pharmaceutical intermediate in the synthesis of various drugs and pharmaceutical compounds. Tert-butyl (1-cyclopentylpiperidin-4-yl)carbamate has been studied for its potential therapeutic effects, particularly in the treatment of neurological disorders and as an antipsychotic agent. Additionally, it has been investigated for its potential use as a pesticide and insect repellent due to its insecticidal properties. tert-Butyl (1-cyclopentylpiperidin-4-yl)carbaMate is important in the field of medicinal chemistry and drug development, and its chemical structure and properties make it a valuable building block for the synthesis of various biologically active molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 936221-73-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,2,2 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 936221-73:
(8*9)+(7*3)+(6*6)+(5*2)+(4*2)+(3*1)+(2*7)+(1*3)=167
167 % 10 = 7
So 936221-73-7 is a valid CAS Registry Number.
936221-73-7Relevant articles and documents
NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS
-
Page/Page column 73, (2014/09/29)
The invention relates to novel acrylamide derivatives of the formula (I) wherein R1, R 2, R 3, X, and ring A are as defined in the description, and their use as active ingredients in the preparation of pharmaceutical compo
2-(SUBSTITUTED-AMINO)-BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS
-
Page/Page column 16, (2008/06/13)
The present invention relates to 2-(substituted-amino)-benzothiazole sulfonamide compounds and derivatives, their use as protease inhibitors, in particular as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present 2-(substituted-amino)-benzothiazole sulfonamide compounds and derivatives with another anti-retroviral agent. It further relates to their use in assays as reference compounds or as reagents.
